Q&A With Scott Whitaker: AdvaMed's Next CEO On The Path Ahead

AdvaMed's board just selected Scott Whitaker, a top executive at the Biotechnology Innovation Organization, as the trade group's next CEO. Before he starts in the new role on April 4, he spoke with The Gray Sheet about his vision.

Scott Whitaker says there are a lot of similarities between the biotech industry and the medical device and diagnostics sector – as well as some important distinctions.

Keeping both in mind will be important as he transitions from the Biotechnology Innovation Organization to AdvaMed, where he will take the helm as CEO in the coming months, filling...

More from Regulation

More from Policy & Regulation